Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.
about
Interventions for rosaceaInterventions for rosaceaSmall intestinal bacterial overgrowth syndromeAcne vulgaris, probiotics and the gut-brain-skin axis - back to the future?Major pathophysiological correlations of rosacea: a complete clinical appraisalAcne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicineGastrointestinal bacterial overgrowth: pathogenesis and clinical significance.Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.Message in a Bottle: Dialog between Intestine and Skin Modulated by Probiotics.Rifaximin pharmacology and clinical implications.Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea.Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response.Recent advances in small bowel diseases: Part I.Human gut microbiota: the links with dementia developmentRefining small intestinal bacterial overgrowth diagnosis by means of carbohydrate specificity: a proof-of-concept study.Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment.How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis.A case of Scalp Rosacea treated with low dose doxycycline and probiotic therapy and literature review on therapeutic options.Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth.Rosacea and gastrointestinal disorders: a population-based cohort study.Rosacea and Helicobacter pylori: links and risks.Atopic dermatitis and the intestinal microbiota in humans and dogs.Response to Paterson et al.Commentary: Towards an effective and safe treatment of small intestine bacterial overgrowth - Authors' reply.Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema.The gut-skin axis in health and disease: A paradigm with therapeutic implications.Diet and rosacea: the role of dietary change in the management of rosacea.Rosacea: Epidemiology, pathogenesis, and treatment.It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients.Commentary: Towards an effective and safe treatment of small intestine bacterial overgrowth.
P2860
Q24186383-C11B1CE4-8A4B-41C9-8E55-29DF037BC248Q24235769-824FACAE-162E-485E-BD6D-C7117C68BC46Q24262889-42F71AC8-2980-497F-889C-F70C4DE7FC4FQ24624433-9F8415BA-0510-48CD-90AE-C6B1BF991718Q28082171-EF4F7836-E4FB-4A0D-B00F-D4B9135410A7Q28295293-B74C80EC-4B96-44E9-9A29-03BF2D358FF8Q33459081-B2F6F569-FB5B-4241-AA2C-17A83AA7ADFFQ33648535-6F0029E3-0177-4D15-A049-B526CA1266C9Q33838310-7E94D714-D529-4253-A6CB-4703C4B7B5F4Q34607677-21E990C6-6C6C-4977-8DD6-DAFE51460DD1Q35044215-47C7C5CC-1CC9-4683-A6CC-DDA605077835Q36081679-0EF3D125-27F3-40A0-A68D-D751F8D89C45Q36093331-63A16D38-2FD0-4DB3-B04C-E33D39567834Q36198753-5DCD97A2-39CF-4AAE-9401-18380D83A187Q36793813-76536430-573B-4BC3-A936-1E18844B5A8FQ38129946-695B1BEA-E9DE-484C-A733-69BC7CBE4959Q38701265-502EBEFD-A686-413E-BBF5-5CCDAD9A03FEQ38764337-F3F6FC40-178F-457C-9259-8D53FF00DCC2Q38810582-D34ABCE1-C66F-471F-9050-003F9C74BCE1Q39081757-9482D36D-84E5-4338-B1E7-F21801C835B7Q39512887-8C555427-B2CA-4FC7-A2A5-682E648B6988Q41389758-8C0407FB-F8B3-4D34-8BF6-8D3E8F86EF0CQ42682689-363CF5DA-3B1F-4547-9315-C7F4F2D032C4Q45981201-9E7EDF22-8D21-404B-A333-B611BF7324D3Q46174063-084730A4-6C7E-4186-B877-646D76425A27Q46311236-6C6DD85F-3D7F-499E-B7C9-C437861A8368Q46471309-8A73BEB3-577F-4360-9AE4-9FBDD8A24E7EQ47103613-89327A55-CF8D-42AC-8C5A-648ECEDB3191Q50324762-F921C0D2-EEC4-429C-A977-FEA663BF8B41Q51462731-865F5642-02E0-4F39-83C3-BAFAF24CB0BFQ54636548-3DF5533A-6B74-4D31-9ABB-0B509BCBEAF4
P2860
Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Small intestinal bacterial ove ...... ectiveness of its eradication.
@ast
Small intestinal bacterial ove ...... ectiveness of its eradication.
@en
Small intestinal bacterial ove ...... ectiveness of its eradication.
@nl
type
label
Small intestinal bacterial ove ...... ectiveness of its eradication.
@ast
Small intestinal bacterial ove ...... ectiveness of its eradication.
@en
Small intestinal bacterial ove ...... ectiveness of its eradication.
@nl
prefLabel
Small intestinal bacterial ove ...... ectiveness of its eradication.
@ast
Small intestinal bacterial ove ...... ectiveness of its eradication.
@en
Small intestinal bacterial ove ...... ectiveness of its eradication.
@nl
P2093
P1476
Small intestinal bacterial ove ...... fectiveness of its eradication
@en
P2093
Alfredo Greco
Andrea Parodi
Aurora Parodi
Carlo Mansi
Francesco Drago
Stefania Paolino
Vincenzo Savarino
P304
P356
10.1016/J.CGH.2008.02.054
P407
P577
2008-05-05T00:00:00Z